Coronary Vascular Articles & Analysis
5 news found
These latest imaging biomarkers strengthen VIDA’s portfolio of airway, tissue, vascular and functional measures. VIDA’s latest airway biomarkers include mucus plug scoring, bronchiectasis scoring, and total airway count (TAC). ...
Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today the opening of its new headquarters at 275 Grove Street in Newton, Mass. ...
Arterius Limited, a Leeds-based, UK company developing innovative medical devices with a focus on next generation bioresorbable coronary and peripheral stents, has announced that it has appointed Steve Parker as Chief Executive Officer. ...
The novel drug Revacept can reduce heart attacks and strokes more efficient and safer than previous standard therapies. This is the result of a study in an investigator initiated study in patients carried out with the German Center for Heart and Circulation Research (DZHK). The study was recently published in JAMA Cardiology. With Revacept severe complications such as heart attacks and stroke in ...
The CathWorks System represents a tremendous opportunity for interventional cardiologists to improve the quality of care and lower costs in the treatment of multivessel coronary artery disease.” Mr. Mousavi said, “I am excited to join CathWorks and I know that physicians and patients will greatly benefit from having an objective, non-invasive platform to routinely ...